Private Wealth Partners LLC cut its position in shares of Danaher Corp. (NYSE:DHR) by 9.1% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 76,456 shares of the company’s stock after selling 7,665 shares during the period. Danaher Corp. comprises approximately 1.9% of Private Wealth Partners LLC’s portfolio, making the stock its 17th largest position. Private Wealth Partners LLC’s holdings in Danaher Corp. were worth $7,722,000 as of its most recent filing with the SEC.
A number of other hedge funds also recently made changes to their positions in the stock. State Street Corp increased its stake in shares of Danaher Corp. by 0.6% in the first quarter. State Street Corp now owns 22,646,064 shares of the company’s stock worth $2,148,210,000 after buying an additional 129,215 shares in the last quarter. BlackRock Fund Advisors boosted its position in shares of Danaher Corp. by 3.3% in the first quarter. BlackRock Fund Advisors now owns 6,928,859 shares of the company’s stock worth $657,272,000 after buying an additional 218,791 shares during the last quarter. Geode Capital Management LLC boosted its position in shares of Danaher Corp. by 5.4% in the first quarter. Geode Capital Management LLC now owns 4,873,827 shares of the company’s stock worth $461,393,000 after buying an additional 249,921 shares during the last quarter. UBS Asset Management Americas Inc. boosted its position in shares of Danaher Corp. by 11.6% in the first quarter. UBS Asset Management Americas Inc. now owns 4,068,557 shares of the company’s stock worth $385,943,000 after buying an additional 421,790 shares during the last quarter. Finally, Findlay Park Partners LLP boosted its position in shares of Danaher Corp. by 1.0% in the first quarter. Findlay Park Partners LLP now owns 3,378,763 shares of the company’s stock worth $320,509,000 after buying an additional 34,303 shares during the last quarter. Institutional investors own 75.74% of the company’s stock.
Danaher Corp. (NYSE:DHR) traded down 0.51% on Monday, hitting $77.99. 2,662,795 shares of the company traded hands. The firm has a market capitalization of $53.86 billion, a P/E ratio of 15.51 and a beta of 1.13. Danaher Corp. has a 12 month low of $61.60 and a 12 month high of $82.64. The stock’s 50-day moving average is $79.15 and its 200 day moving average is $76.40.
Danaher Corp. (NYSE:DHR) last released its quarterly earnings data on Monday, July 25th. The company reported $1.25 earnings per share (EPS) for the quarter, topping the Thomson Reuters’ consensus estimate of $1.22 by $0.03. Danaher Corp. had a net margin of 15.88% and a return on equity of 13.40%. The firm earned $5.80 billion during the quarter, compared to analysts’ expectations of $5.76 billion. During the same period last year, the business earned $1.08 earnings per share. Danaher Corp.’s revenue was up 16.6% compared to the same quarter last year. Equities analysts forecast that Danaher Corp. will post $3.56 EPS for the current fiscal year.
The business also recently announced a quarterly dividend, which will be paid on Friday, October 28th. Shareholders of record on Friday, September 30th will be paid a dividend of $0.125 per share. This represents a $0.50 annualized dividend and a yield of 0.64%. The ex-dividend date of this dividend is Wednesday, September 28th. Danaher Corp.’s dividend payout ratio (DPR) is presently 9.94%.
A number of equities analysts have commented on DHR shares. Goldman Sachs Group Inc. started coverage on shares of Danaher Corp. in a research note on Tuesday, July 5th. They issued a “neutral” rating and a $74.00 price objective for the company. Zacks Investment Research raised shares of Danaher Corp. from a “hold” rating to a “buy” rating and set a $86.00 price objective for the company in a research note on Tuesday, September 27th. Jefferies Group reissued a “buy” rating on shares of Danaher Corp. in a research note on Thursday, September 8th. Barclays PLC reissued an “overweight” rating and issued a $105.00 price objective on shares of Danaher Corp. in a research note on Monday, June 27th. Finally, Sanford C. Bernstein raised shares of Danaher Corp. from a “market perform” rating to an “outperform” rating and set a $120.00 price objective for the company in a research note on Thursday, June 23rd. Nine research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. Danaher Corp. currently has a consensus rating of “Buy” and a consensus price target of $93.98.
In other Danaher Corp. news, insider Thomas Patrick Joyce, Jr. sold 45,897 shares of the stock in a transaction dated Monday, August 1st. The shares were sold at an average price of $81.44, for a total transaction of $3,737,851.68. Following the completion of the transaction, the insider now owns 179,054 shares of the company’s stock, valued at $14,582,157.76. The sale was disclosed in a legal filing with the SEC, which is available at this link. Also, CFO Daniel L. Comas sold 96,446 shares of the stock in a transaction dated Wednesday, July 27th. The stock was sold at an average price of $80.88, for a total transaction of $7,800,552.48. Following the transaction, the chief financial officer now directly owns 215,716 shares of the company’s stock, valued at approximately $17,447,110.08. The disclosure for this sale can be found here. Company insiders own 12.60% of the company’s stock.
Danaher Corp. Company Profile
Danaher Corporation designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates in five segments: Test & Measurement; Environmental; Life Sciences & Diagnostics; Dental, and Industrial Technologies. Its Test & Measurement segment offers products, software and services.
Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Corp. (NYSE:DHR).
Receive News & Ratings for Danaher Corp. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher Corp. and related companies with MarketBeat.com's FREE daily email newsletter.